GlassScriptPhysician profile
Vail M Brennan
NPI 1407131907
$3,611.00
in general payments reported to CMS, 2019-2025
26 companies · $963 in 2025
The $963 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $221 · 2020: $12.30 · 2021: $267 · 2022: $1,579 · 2023: $330 · 2024: $239 · 2025: $963.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $900 · Food and Beverage: $563 · Education: $68.14.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $900.00 |
| Food and Beverage | $563.49 |
| Education | $68.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $1,480.00 | 2022 | |
| Olympus Winter & Ibe Gmbh | $500.00 | 2025 | Endoeye Flex Deflectable Videoscope |
| Atrium Medical Corporation | $400.00 | 2025 | Flixene |
| Lexington Medical, INC. | $114.63 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $104.34 | 2022-2023 | Gattex |
| W. L. Gore & Associates, INC. | $95.54 | 2021-2025 | Gore Bio-A Tissue Reinforcement, Gore Synecor Biomaterial |
| Intuitive Surgical, INC. | $90.17 | 2019 | |
| Kerecis Limited | $89.64 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Novo Nordisk INC | $77.24 | 2019-2023 | Wegovy |
| Conmed Corporation | $74.25 | 2019-2023 | Airseal |
| Tela Bio, INC. | $73.62 | 2022-2024 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Ethicon US, LLC | $72.36 | 2019-2023 | Linx Reflux Management System |
| Medtronic, INC. | $56.85 | 2021-2024 | Progrip |
| Abbvie INC. | $55.98 | 2023 | Dalvance |
| Heron Therapeutics, INC. | $51.56 | 2022-2024 | Zynrelef, Aponvie |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $47.96 | 2021-2024 | Exparel |
| Surgical Specialties Corporation (US), INC. (Dba Corza Medical) | $39.49 | 2025 | |
| Innovation Technologies INC | $37.63 | 2024 | Irrisept |
| Allergan, INC. | $28.57 | 2019 | |
| Corcept Therapeutics | $23.70 | 2024 | Korlym |
| Lsi Solutions INC | $21.71 | 2019 | |
| Solventum Corporation | $16.70 | 2024 | V.A.C. Veraflo, V.A.C. Veraflo Cleanse Choice, Prevena |
| Kci USA, INC. | $16.61 | 2022 | |
| Innocoll Pharmaceuticals Limited | $15.33 | 2021 | |
| Avinger INC. | $14.62 | 2023 | Pantheris |
| Integra Lifesciences Corporation | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vail Brennan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.